SCHOTT Pharma AG & Co. KGaA (BIT:1SXP)
Italy · Delayed Price · Currency is EUR 15.92
+1.80 (12.75%)
At close: Feb 11, 2026
BIT:1SXP Revenue
SCHOTT Pharma AG & Co. KGaA had revenue of 240.19M EUR in the quarter ending December 31, 2025, with 4.50% growth. This brings the company's revenue in the last twelve months to 995.03M, up 4.23% year-over-year. In the fiscal year ending September 30, 2025, SCHOTT Pharma AG & Co. KGaA had annual revenue of 986.21M with 3.04% growth.
Revenue (ttm)
995.03M
Revenue Growth
+4.23%
P/S Ratio
2.23
Revenue / Employee
210.99K
Employees
4,811
Market Cap
2.21B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 986.21M | 29.12M | 3.04% |
| Sep 30, 2024 | 957.09M | 58.49M | 6.51% |
| Sep 30, 2023 | 898.60M | 77.46M | 9.43% |
| Sep 30, 2022 | 821.14M | 172.48M | 26.59% |
| Sep 30, 2021 | 648.67M | 64.44M | 11.03% |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| MFE-Mediaforeurope | 2.88B |
| Ariston Holding | 2.68B |
| Amplifon | 2.41B |
| Cementir Holding | 1.67B |
| ENAV S.p.A. | 989.17M |
| Banca IFIS | 664.55M |
| Carel Industries | 609.33M |
| Avio S.p.A. | 549.03M |